Showing results (2331-2340 of 2,672) with videos related to

Sort By:
Pageof 268
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 14, 2024
Urinary eosinophil-derived neurotoxin is associated with reduced lung function in pediatric asthmaJimmy Omony, Clemens Thölken, Azam Salimi, et al.
Chest|February 2, 2025
Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUSSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
The Lancet. Respiratory Medicine|December 9, 2024
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trialDave Singh, Christopher E Brightling, Klaus F Rabe, et al.
Pediatric Research|December 26, 2018
Recommendations for the design of therapeutic trials for neonatal seizuresJanet S Soul, Ronit Pressler, Marilee Allen, et al.
The European Respiratory Journal|September 11, 2017
Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guidelineJadwiga A Wedzicha, Peter M A Calverley, Richard K Albert, et al.
Neurology|April 27, 2018
ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer diseaseJeffrey L Cummings, Sharon Cohen, Christopher H van Dyck, et al.
Immunobiology|November 26, 2025
Higher levels of urinary extracellular vesicles and immune mediators are related to acute infection severity during the post-COVID periodEvelyn Maciel de Oliveira, Camila Carvalho, Natalia Fonseca do Rosário, et al.
Frontiers in Immunology|November 21, 2025
Soluble HLA-G is related to malignant melanocytic lesions and previous oncological disease may increase circulating HLA-G bearing large extracellular vesiclesKianny Kimberly Silva-Krebs, Evelyn Maciel de Oliveira, Carlos Arthur Athayde, et al.
The Lancet. Respiratory Medicine|February 3, 2025
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trialsSurya P Bhatt, Klaus F Rabe, Nicola A Hanania, et al.
Respiratory Research|January 8, 2017
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary diseaseColin Reisner, Leonardo M Fabbri, Edward M Kerwin, et al.
Pageof 268